Search results for "Mental disorders"

showing 10 items of 1528 documents

The behaviour of OKT3-, OKT4- and OKT8-positive cells during phases of elevated spontaneous chemiluminescence activity (CL-A) in multiple sclerosis p…

1987

The chemiluminescence activity (CL-A; synonym = burst activity, BA) and the percentage of OKT3-, OKT4- and OKT8-positive peripheral blood cells were serially examined in four control persons and in eight patients with multiple sclerosis. When the OKT values obtained in phases of increased CL-A (clinical remission) were compared with those of the control group, the percentage of OKT3-positive cells was reduced (P = 0.014), and that of OKT4-positive cells increased (P = 0.014); there were no significant changes in the percentage of OKT8-positive cells (P = 0.171). After the CL-A had returned to normal values, the OKT4-positive cells remained elevated (P = 0.029), whereas the OKT3- (P = 0.342)…

AdultMalePathologymedicine.medical_specialtyMultiple SclerosisT-Lymphocyteschemical and pharmacologic phenomenaNormal valuesT-Lymphocytes RegulatoryMonocyteslaw.inventionlawInternal medicinemental disordersmedicineHumansChemiluminescencebusiness.industryMonocyteMultiple sclerosishemic and immune systemsT lymphocyteT-Lymphocytes Helper-Inducermedicine.diseasePeripheral bloodEndocrinologymedicine.anatomical_structureNeurologyLuminescent MeasurementsFemaleNeurology (clinical)businesspsychological phenomena and processesJournal of neurology
researchProduct

Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remissio…

2019

Despite being recommended for use in clinical trials, the consensus remission criteria were found to leave patients with persisting symptoms, relevant areas of functional impairment and a decreased sense of wellbeing. Therefore, to evaluate the appropriateness of the schizophrenia consensus criteria, a definition of remission based on the Clinical Global Impression Scale (CGI) was developed and remitter subgroups were compared.239 patients with a schizophrenia spectrum disorder were evaluated regarding their remission status after inpatient treatment. Remission in schizophrenia was defined according to the symptom-severity component of the consensus criteria by Andreasen et al. and a CGI ba…

AdultMalePediatricsmedicine.medical_specialtyConsensusMedizinConsensus criteriaSeverity of Illness IndexAsymptomaticYoung Adult03 medical and health sciences0302 clinical medicineRemission criteriaOutcome Assessment Health Caremental disordersmedicineHumansBiological PsychiatryDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryRemission InductionMiddle Agedmedicine.disease030227 psychiatry3. Good healthClinical trialPsychiatry and Mental healthSchizophreniaSchizophreniaClinical Global ImpressionFemalemedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesSchizophrenia spectrum
researchProduct

Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study.

2016

Objective: The CAT ( Comorbilidad en Adultos con TDAH) study aimed to quantify and characterize the psychiatric comorbidity at the time of diagnosis of ADHD in adult outpatients. Method: Cross-sectional, multicenter, observational register of adults with ADHD diagnosed for the first time. Results: In this large sample of adult ADHD ( n = 367), psychiatric comorbidities were present in 66.2% of the sample, and were more prevalent in males and in the hyperactive-impulsive and combined subtypes. The most common comorbidities were substance use disorders (39.2%), anxiety disorders (23%), and mood disorders (18.1%). In all, 88.8% patients were prescribed pharmacological treatment for ADHD (in 9…

AdultMalePediatricsmedicine.medical_specialtyCross-sectional studySubstance-Related DisordersComorbidity03 medical and health sciencesPsychiatric comorbidity0302 clinical medicinemental disordersOutpatientsDevelopmental and Educational PsychologymedicinePrevalenceHumansSex DistributionPsychiatryMethylphenidatebusiness.industryMood DisordersMental Disordersmedicine.diseaseComorbidityAnxiety Disorders030227 psychiatryClinical PsychologyCross-Sectional StudiesMood disordersAttention Deficit Disorder with HyperactivityMethylphenidateAnxietyObservational studyFemalemedicine.symptomSubstance usebusiness030217 neurology & neurosurgerymedicine.drugJournal of attention disorders
researchProduct

Oral manifestations in a group of adults with autism spectrum disorder

2011

Objective: A number of studies have evaluated the oral health of patients with autism spectrum disorder (ASD), though most have involved children, and no specific oral manifestations have been described. The present study describes the buccodental disorders and hygiene habits in a group of adults with ASD. Study Design: A prospective case-control study was made of a group of patients with ASD (n=30), with a mean age of 27.7 +/- 5.69 years, and of a healthy age-and gender-matched control group (n=30). An evaluation was made of the medical history, medication, oral hygiene habits and oral diseases, with determination of the CAOD, CAOS and OHI-S oral hygiene scores. Results: Most of the patien…

AdultMalePediatricsmedicine.medical_specialtymedia_common.quotation_subjectPopulationDentistryOral hygieneYoung AdultHygienemental disordersmedicineHumansMedical historyProspective StudiesYoung adultAutism spectrum disorderChildProspective cohort studyeducationGeneral Dentistrymedia_commoncarieseducation.field_of_studybusiness.industryCase-control studyOdontostomatology for the Disabled or Special PatientOral Hygiene:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseoral manifestationsstomatognathic diseasesOtorhinolaryngologyChild Development Disorders PervasiveAutism spectrum disorderCase-Control StudiesUNESCO::CIENCIAS MÉDICASdental hygieneResearch-ArticleFemaleSurgeryMouth Diseasesbusiness
researchProduct

Examining the Dynamics of the Implicit and the Explicit Self-Concept in Social Anxiety: Changes in the Implicit Association Test–Anxiety and the Soci…

2008

In this study, we analyzed changes in the strength of self-anxiety associations—as measured by the Implicit Association Test–Anxiety (IAT–Anxiety; Egloff & Schmukle, 2002) and the Social Phobia Anxiety Inventory (SPAI; Turner, Beidel, Dancu, & Stanley, 1989)—following treatment of social anxiety. We assessed socially anxious participants (N = 24) prior to and following a group-based treatment; and we assessed healthy controls (N = 24) at matched time points. Results showed (a) higher implicit and explicit anxiety in socially anxious participants (as compared to controls) prior to treatment and (b) reductions in IAT–Anxiety and SPAI scores of socially anxious participants following treatment…

AdultMalePersonality InventoryPsychometricsHealth Toxicology and Mutagenesismedia_common.quotation_subjectSelf-conceptDevelopmental psychologyArts and Humanities (miscellaneous)GermanySurveys and Questionnairesmental disordersmedicineHumansPersonalitymedia_commonSocial anxietySocial environmentImplicit-association testmedicine.diseaseSelf ConceptClinical PsychologyTreatment OutcomePhobic DisordersCase-Control StudiesPsychotherapy GroupAnxietyFemalemedicine.symptomPsychologyAnxiety disorderFollow-Up StudiesJournal of Personality Assessment
researchProduct

Subjective Perception of Cognitive Deficit in Psychotic Patients

2006

The objective of this study is to evaluate the subjective perception of cognitive deficit and how it relates to the perception of patients' relatives. Differences between the subjective perception of cognitive deficits in 107 DSM-IV-diagnosed psychotic patients and that of their relatives or caregivers were evaluated using the GEOPTE Scale. Fair agreement was observed between patient and family perception of cognitive functions, although there were important differences on those items that correspond to social functioning. A high degree of correlation was detected between the scores on this scale and clinical global impression scores, as well as the physicians' global impression of cognitiv…

AdultMalePersonality Inventorygenetic structuresPsychometricsAttitude of Health PersonnelHealth Statusmedia_common.quotation_subjectbehavioral disciplines and activitiesDevelopmental psychologySurveys and QuestionnairesPerceptionmedicineHumansCognitive deficitmedia_commonFamily HealthPsychiatric Status Rating ScalesPsychiatrySocial perceptionCognitive disorderCognitionAwarenessmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthCaregiversPsychotic DisordersSocial PerceptionSchizophreniaClinical Global ImpressionFemalemedicine.symptomCognition DisordersPsychologyAttitude to HealthSocial Adjustmentpsychological phenomena and processesJournal of Nervous & Mental Disease
researchProduct

Using Implicit Association Tests for the assessment of implicit personality self-concepts of extraversion and neuroticism in schizophrenia

2013

There is evidence from research based on self-report personality measures that schizophrenia patients tend to be lower in extraversion and higher in neuroticism than healthy individuals. Self-report personality measures assess aspects of the explicit self-concept. The Implicit Association Test (IAT) has been developed to assess aspects of implicit cognition such as implicit attitudes and implicit personality traits. The present study was conducted to investigate the applicability and reliability of the IAT in schizophrenia patients and test whether they differ from healthy individuals on implicitly measured extraversion and neuroticism. The IAT and the NEO-FFI were administered as implicit …

AdultMalePersonality TestsAdolescentgenetic structuresImplicit cognitionmedia_common.quotation_subjectSchizophrenia (object-oriented programming)Developmental psychologyAssociationExtraversion PsychologicalYoung AdultCognitionmental disordersHumansPersonalityBiological Psychiatrymedia_commonImplicit personality theoryNeuroticismExtraversion and introversionReproducibility of ResultsImplicit-association testMiddle AgedAnxiety DisordersNeuroticismSelf ConceptPsychiatry and Mental healthFemaleSchizophrenic PsychologyImplicit attitudePsychologyPersonalityPsychiatry Research
researchProduct

Avoidance behaviour: A predictor of the efficacy of pharmacotherapy in panic disorder?

1991

The impact of the avoidance behaviour on the psychopharmacological treatment of panic disorder was explored in the Cross National Collaborative Panic Study (n = 1134 patients); in this double blind randomized trial alprazolam, imipramine and placebo were compared during an 8-week treatment period. Patients with extensive avoidance behaviour (agoraphobia) had the most profit from the active drugs. Counter expectancy these specific drug effects were most pronounced in avoidance behaviour. Active drugs (in particular imipramine) were especially more effective than placebo if the patients presented with associated avoidance behaviour. The results suggest that agoraphobia defines more a particul…

AdultMalePersonality TestsImipraminemedicine.medical_specialtyPlacebobehavioral disciplines and activitiesImipraminelaw.inventionDouble-Blind MethodRandomized controlled triallawmental disordersmedicineHumansPharmacology (medical)Social BehaviorPsychiatryAgoraphobiaBiological PsychiatryAlprazolamPanic disorderPanicFearGeneral Medicinemedicine.diseasePanichumanitiesPsychiatry and Mental healthAlprazolamPanic DisorderFemalemedicine.symptomArousalPsychologyAnxiety disordermedicine.drugAgoraphobiaClinical psychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborati…

1991

The relevance of the chronology between panic disorder and avoidance behavior and of an early, medium or late onset of panic disorder was tested. Groups from the sample of the cross-national collaborative panic study (CNCPS) were compared for differences in basic characteristics and for the ability to predict treatment response. Patients who developed avoidance behavior before the full syndrome of panic disorder had less often a full agoraphobia but were not different in their response to treatment. Patients with an early onset of panic disorder suffered more often from agoraphobia. The treatment response was similar in the groups with early, medium or late onset of panic disorder. Neither …

AdultMalePersonality Testsmedicine.medical_specialtyImipramineLate onsetbehavioral disciplines and activitiesImipramineDrug Administration Schedulelaw.inventionRandomized controlled triallawmental disordersmedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAlprazolamGeneral NeurosciencePanic disorderAge FactorsPanicGeneral MedicineMiddle Agedmedicine.diseasePrognosisAnxiety DisordersPanichumanitiesPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAlprazolamFemalemedicine.symptomAge of onsetPsychologyArousalmedicine.drugClinical psychologyAgoraphobiaEuropean archives of psychiatry and clinical neuroscience
researchProduct

Escitalopram causes fewer seizures in human overdose than citalopram

2010

Seizures are a recognized complication of acute overdose with the racemic (1:1 ratio of R- and S-enantiomers) selective serotonin reuptake inhibitor antidepressant citalopram.We tested the hypothesis that escitalopram (the therapeutically active S-enantiomer of citalopram) causes fewer seizures in overdose than citalopram at comparable doses of the S-enantiomer.Multicenter retrospective review of cases with citalopram and escitalopram overdose reported to German, Austrian, and Swiss Poisons Centers between 1997 and 2006.316 citalopram and 63 escitalopram cases were analyzed. Somnolence, nausea, vomiting, tachycardia, QT prolongation, and tremor occurred with similar frequency in both groups…

AdultMalePoison Control CentersAdolescentNauseaSerotonin reuptake inhibitor610 Medicine & healthCitalopramCitalopramToxicologyDrug overdosebehavioral disciplines and activitiesQT intervalYoung AdultSeizuresGermanymental disordersmedicineHumansEscitalopramAgedRetrospective StudiesAged 80 and over3005 ToxicologyStereoisomerismGeneral MedicineMiddle Agedmedicine.disease10199 Clinic for Clinical Pharmacology and ToxicologyAustriaAnesthesiaVomitingAntidepressantFemaleDrug Overdosemedicine.symptomPsychologySelective Serotonin Reuptake InhibitorsSwitzerlandmedicine.drug
researchProduct